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Background: To evaluate the clinical utility of spectral analysis of intraocular pressure pulse wave in healthy eyes of
a control group (CG), patients having glaucomatous optic disc appearance or ocular hypertension, and patients
with primary open angle glaucoma or primary angle closure glaucoma.
Methods: This is a prospective study that enrolled 296 patients from a single glaucoma clinic. Age matched CG
consisted of 62 individuals. Subjects underwent comprehensive clinical diagnostic procedures including intraocular
pressure (IOP) measurement with dynamic contour tonometry (DCT) and Goldmann applanation tonometry (GAT). DCT
time series were analyzed with custom written software that included signal preprocessing, filtering and spectral
analysis. An amplitude and energy content analysis, which takes into account non-stationarity of signals but also
provides methodology that is independent of IOP and ocular pulse amplitude (OPA) levels, was applied. Spectral
content up to the 6th harmonic of the pressure pulse wave was considered. Statistical analyses included descriptive
statistics, normality test, and a multicomparison of medians for independent groups using Kruskal-Wallis test.
Results: GAT IOP showed statistical significance (Kruskal-Willis test p < 0.05) for three out of 10 considered multiple
comparisons, DCT IOP and OPA showed statistically significant results in five and seven cases, respectively. Changes in
heart rate and central corneal thickness between the groups were statistically significant in two cases. None of the
above parameters showed statistically significant differences between CG and the suspects with glaucomatous optic
disc appearance (GODA). On the other hand, spectral analysis showed statistically significant differences for that case.
Conclusions: Spectral analysis of the DCT signals was the only method showing statistically significant differences
between healthy eyes and those of GODA suspects.
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Cataract, age related macular degeneration and glaucoma
are the leading causes of blindness in the developed coun-
tries. There are an estimated 60 million people with glau-
comatous optic neuropathy and over 8 million blind people
as the result of glaucoma [1]. In its early stages, glaucoma is
asymptomatic and often difficult to diagnose. Measurement
of the intraocular pressure (IOP) is regularly performed
during early examination as well as follow-up of glaucoma
patients. Although increased IOP is one of the risk factors
in glaucoma, it is the vascular theory underlining blood
supply deregulation that might be involved in the patho-
genesis of glaucomatous optic neuropathy [2] and the* Correspondence: magdalena.asejczyk@pwr.edu.pl
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article, unless otherwise stated.corresponding structural and function loss that define it [3].
Nevertheless, currently the IOP seems to be the only modi-
fiable factor in treating glaucoma [4,5].
Physiological fluctuations in IOP occur with the heart
rate (HR). The difference between diastolic and systolic
IOP is being referred to as the ocular pulse amplitude
(OPA) [6-9]. It was reported that glaucoma patients display
reduced OPA and reduced pulsatile ocular blood flow in
comparison to control group of healthy subjects [10,11].
Those correlative results showed some potential of OPA as
a diagnostic parameter, which currently is not routinely
taken into account in diagnosis. Since IOP is utilized in
glaucoma diagnosis and management, ideally, it should be
obtained, as is the OPA, in a dynamic fashion from the re-
cording of the intraocular pressure pulse wave.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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sured with pneumatonometer or the dynamic contour ton-
ometer (DCT, Pascal, Ziemer Ophthalmic System AG,
Switzerland). In DCT, the pressure is measured directly on
the external surface of the cornea, which according to the
condition of matched contours [12,13] is theoretically
equal to that inside the eye. DCT output contains a time
series of several periods of the pressure pulse wave from
which average diastolic IOP and maximum OPA values
can be obtained. It was demonstrated that IOP parameters
obtained from DCT are independent of geometrical and
biomechanical properties of the cornea [12-14] but there
are reports suggesting the contrary [15].
Evans and colleagues [16] were the first to report that
spectral information of the intraocular pressure pulse
wave, measured in their case with a pneumatonometer,
can be utilized to distinguish glaucoma patients from nor-
mal subjects. In a small study of 10 normal subjects and
10 untreated glaucoma patients, they showed that the 2nd,
3rd and 4th harmonic components of the IOP pulse wave
were significantly different between the groups. Recently,
Božić and colleagues [17] have performed a similar study
including a control group of 20 subjects and two groups
of glaucoma patients including 20 with primary open
angle glaucoma and 20 with normal tension glaucoma.
There again, the spectral content of the intraocular pres-
sure pulse wave, measured with DCT, showed differences
between the groups.
The objective of this study was to ascertain, on a larger
pool of subjects and patients than those used in studies of
Evans and colleagues [16] and Božić and colleagues [17],
whether spectral analysis of the intraocular pressure pulse
wave has any added value to the traditional clinical tech-
niques based on GATand DCT.
Methods
This prospective study included 296 participants (104
males and 192 females) enrolled from the regular patients
of the Glaucoma Clinic at the Department of Ophthalmol-
ogy, Wrocław Medical University. Sixty two age matched
volunteers (19 males and 43 females) with no ocular and
systemic pathologies were recruited from the university
staff and their family members to form a control group
(CG). The group of patients was further divided into four
subgroups including those diagnosed:
(i) with the primary open angle glaucoma (POAG);
diagnosis of POAG was based on glaucomatous
changes in the optic nerve head with corresponding
visual field defects and high or normal IOP in the
presence of an open angle
(ii) with the primary angle closure glaucoma (PACG);
diagnosis of PACG was based on glaucomatous
changes in the optic nerve head withcorresponding visual field defects in the presence
of an anatomically narrow angle
(iii) as glaucoma suspects based on ocular hyper
tension (OHT); diagnosis of OHT was applied to
cases with IOP ≥ 21 mmHg, no glaucomatous
changes in the optic nerve head, normal visual
fields, and an open angle
(iv) as glaucoma suspects with glaucomatous optic disc
appearance (GODA); diagnosis of GODA was
determined by clinical assessment (narrowing of
the neuroretinal rim with optic cup concentric
enlargement, localized notching, or both), but
normal visual fields and an open angle.
Subjects were fully informed of the purpose of the
study and all procedures and their requirements. In-
formed subject consent was obtained before any mea-
surements were taken. The project was approved by the
Ethics Committee of the Wrocław Medical University
(KB 481/2009) and adhered to the Tenets of the Declar-
ation of Helsinki. The criteria for exclusion from the
study were: any systemic disease, intraocular surgery
less than six months before the study start date, refract-
ive surgery, conjunctival or intraocular inflammation,
corneal abnormalities such as edema or scars, and con-
tact lens wear.
None of the subjects was taking any systemic medica-
tions. In the POAG and PCAG groups, patients were taking
beta-blocker drops (27% and 30%, respectively), prostaglan-
dins (36% and 32%), carbonic anhydrase inhibitor eye drops
(28% and 19%) and alpha agonists (9% and 19%). Seventeen
percent and 31% of patients were taking medications in the
OHT and GODA group, respectively. Patients were taking
beta-blocker drops (12% and 11%, respectively), prostaglan-
dins (7% and 20%), carbonic anhydrase inhibitor eye drops
(8% and 7%) and alpha agonists (1% and 3%).
A comprehensive clinical protocol was used in the fol-
lowing order:
[1] Review of general and medical ophthalmological
history;
[2] Best corrected distance and near visual acuity;
[3] Central corneal thickness (CCT) measurement
(PalmScan AP2000 A-Scan Biometer, MicroMedical
Devices Inc., Calabasas, CA, USA) after instillation of
one drop of 0.5% Alcaine (Proparacaine Hydrochlor-
ide, Alcon-Couvreur).
[4] Dynamic contour tonometry with anesthesia
(DCT); continuous IOP pulse wave recordings
were taken at a sampling rate of 100 Hz; the
average (mean ± standard deviation) recording
time of the IOP pulse wave for all subjects was
20.0 ± 4.6 seconds. Measurements were repeated
until three IOP recordings with a quality score Q
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data from the DCT included estimates of IOP, OPA,
and HR.
[5] Goldman applanation tonometry; one drop of 2%
Thilorbin (Fluorescein Sodium, Oxybuprocaine
Hydrochloride, Alcon Pharma GmbH) was then
entered into the conjunctival sac 30 seconds
before the GAT measurement; three
measurements were taken for the mean IOP value.
GAT measurement was masked with respect to
the measurement of DCT. Tonometry
measurements were not randomized but sufficient
time between measurements was allocated to
avoid possible bias.
Additionally, after half an hour break, the glaucoma
clinic patients underwent
[6] optic nerve head examination with Heidelberg
scanning laser ophthalmoscope examination
(HRT 3, Heidelberg Engineering, Heidelberg,
Germany) after topical cycloplegia with sol. 1%
Tropicamide,
[7] posterior segment examination with optical
coherence tomography (sOCT, Copernicus,
Optopol, Zawiercie, Poland)
[8] automated visual field examination using the Octopus
101 perimeter (Interzeag/Haag-Streit, Koeniz-Bern,
Switzerland) were performed with dynamic test strat-
egy (threshold algorithm, program G1).Figure 1 An example of the raw pulse pressure wave from Pascal DC
filter wave (C) and the spectral content containing the first 6 harmonDCT time series of the intraocular pressure pulse wave
were saved and analyzed with custom written software,
written in MATLAB (MathWorks, Natick, MA, USA),
that included signal preprocessing, filtering and spectral
analysis. The preprocessing step consisted of extracting
the working range of the pulse pressure wave from raw
Pascal data file (see Figure 1A and 1B) and removal of
the signal trend (so-called detrending procedure). Signal
filtering was achieved with the Savitzky-Golay filter [21]
of order three with a smoothing window of length equal
to 15 samples (see Figure 1C). Filtering raw DCT signal
was necessary to increase the efficacy of subsequent spec-
tral analysis. Spectral content of the IOP wave was ob-
tained with a consistent power spectral estimator based on
the windowed periodogram (fast Fourier transform, FFT).
The Hamming window applied in the time domain was
used. The FFT length was set to 4096 samples, regardless
of the length of the measured signal to allow direct com-
parison between different spectral signal representations.
Spectral content up to the 6th harmonic of the pressure
pulse wave was considered (see Figure 1D).
Previous attempts of analyzing the spectral content of
the intraocular pulse signals focused on estimating the
amplitudes of each signal harmonic [16,17]. Such an ap-
proach is prone to errors due to inherent nonstationarity
of signals caused mainly by the heart rate variability and
respiratory sinus arrhythmia [22]. Nonstationarity means
that the signal frequency spectrum varies in time [23]. To
minimize this unwanted effect, two measures of spectral
content were considered:T (A), the extracted working range wave (B), the detrended and
ics (D).
Table 1 Number of subjects, mean age, GAT IOP, DCT IOP, OPA, HR and CCT for the five considered groups
Variables CG Suspects group POAG PACG
GODA OHT
Number of subjects (M/F) 62 (19/43) 43 (11/32) 31 (16/15) 197 (68/129) 25 (9/16)
Mean age (years ± SD) (range) 68 ± 11 (41 ÷ 87) 62 ± 14 (41 ÷ 86) 61 ± 11 (41 ÷ 81) 66 ± 11 (40 ÷ 86) 65 ± 9 (41 ÷ 75)
Mean GAT IOP
(mmHg ± SD) (range)
14 ± 3 (8 ÷ 22) 15 ± 3 (10 ÷ 20) 21 ± 1 (19 ÷ 26) 16 ± 4 (9 ÷ 31) 16 ± 3 (10 ÷21)
Mean DCT IOP
(mmHg ± SD) (range)
16.9 ± 2.6 (10.3 ÷ 24.3) 17.4 ± 2.3 (9.9 ÷ 21.0) 22.7 ± 2.8 (18.4 ÷ 31.8) 18.5 ± 4.2 (7.9 ÷ 39.7) 17.5 ± 3.5 (12.4 ÷ 46.9)
Mean OPA
(mmHg ± SD) (range)
2.9 ± 1.3 (0.6 ÷ 6.6) 2.7 ± 1.1 (0.9 ÷ 5.3) 4.1 ± 1.6 (0.9 ÷ 8.5) 3.1 ± 1.4 (0.5 ÷ 9.2) 3.8 ± 1.3 (1.3 ÷ 6.8)
Mean HR (bpm ± SD) (range) 70 ± 8 (53 ÷ 94) 73 ± 11 (52 ÷ 109) 70 ± 11 (54 ÷ 115) 70 ± 8 (43 ÷ 172) 72 ± 14 (52 ÷ 97)
Mean CCT (μm± SD) (range) 561 ± 43 (478 ÷ 670) 545 ± 33 (450 ÷ 595) 574 ± 31 (538 ÷ 665) 550 ± 40 (424 ÷ 648) 559 ± 28 (509 ÷ 621)
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pulse wave and that of the first (principal) harmonic,
An /A1, n = 2, 3, …, 6.
(ii) the ratio of spectral harmonic energy of the IOP
pulse wave and that of the first (principal) harmonic,
Sn /S1, n = 2, 3,…, 6, where the harmonic energy was
calculated, using numerical integration, as the area
of +/−0.2 Hz around the harmonic amplitude.
It should be noted that the proposed spectral analysis
approach does not consider the effect of IOP level (sig-
nals were detrended) and the effect of OPA amplitude
(ratios of amplitudes and energies were used).
Statistical analysis included standard descriptive stat-
istic. All data were tested for normality using the
Jarque-Bera test. Normality was rejected in the majority
of cased (p < 0.05) as the data distributions were often
skewed. Hence, multicomparison for independent groups
has been performed using Kruskal-Wallis test (Statistica,
ver. 10, StatSoft, Inc., USA).Table 2 The results of the Kruskal-Wallis test (p-values) for m
GAT IOP D
GODA OHT POAG PACG GODA OHT
CG NS <0.001 NS NS NS <0.001




GODA OHT POAG PACG GODA OHT
CG NS NS <0.010 NS NS NS
GODA NS <0.001 NS <0.010
OHT NS NS
POAG NS
Statistically significant results (p < 0.05) are shown in bold font. NS denotes a statistResults
The main group demographics together with the group
mean GAT IOP, DCT IOP, OPA, HR and CCT are
shown in Table 1. There were statistically significant dif-
ferences (Kruskal-Willis test p < 0.05) between median
ages within subject groups but the ranges were similar.
The results of a multiple comparison of medians using
the Kruskal-Wallis test for GAT IOP, DCT IOP, OPA, HR
and CCT are shown in Table 2. For GAT IOP significant
differences (p < 0.05) were found between three pairs of
considered groups, that is, between CG and OHT, GODA
and OHT, and between PACG and OHT. For DCT IOP,
significant differences were recorded for five out of 10 mul-
tiple comparisons. Significant differences (p < 0.05) were
found between OHT and all other groups, and between
CG and POAG. OPA showed statistically significant differ-
ences in seven cases. No significant differences were found
between CG and GODA, CG and POAG, and between
OHT and PACG. HR and CCT showed statistically signifi-
cant differences in only two cases each.ulti-comparison of medians of the five considered groups
CT IOP OPA
POAG PACG GODA OHT POAG PACG
<0.001 NS NS <0.001 NS <0.001
NS NS <0.001 <0.050 <0.001





































A2/A1 A3/A1 A4/A1 A5/A1 A6/A1
Figure 2 The ratios of spectral harmonic amplitudes of the IOP pulse wave and that of the first (principal) harmonic, normalized with
respect to the control group average.
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were found between CG and POAG and between
GODA and POAG. Note that the fundamental fre-
quency of the Pascal DCT signal, estimated using a
spectral analysis method that takes into account non-
stationarity of signals, corresponds very closely to the
HR value given by Pascal instrument.
For CCT significant differences were found between
GODA and OHT and between OHT and POAG.
Figure 2 shows the ratios of spectral harmonic ampli-
tudes (A2, A3, A4, A5, and A6) of the IOP pulse wave and
that of the first (principal) harmonic (A1), normalized
with respect to the control group average. Correspond-
ingly, Figure 3 shows the ratios of spectral harmonic en-
ergies (S2, S3, S4, S5, and S6) and that of the first
(principal) harmonic (S1), normalized with respect to
the control group average. Error bars in both figures in-























Figure 3 The ratios of spectral harmonic energies of the IOP pulse wa
respect to the control group average.Separation trends between the groups were observed for
both ratios of spectral harmonic amplitudes and energies,
where this effect was more pronounced for the latter. Note
that the considered spectral ratios do not indicate differ-
ences in the IOP and OPA levels but differences in the
IOP pulse wave shape. The higher the harmonic frequency
the larger the separation trend was obtained. This was,
however, at the cost of larger noise, resulting in non-
significant differences in the statistical analyses.
For the amplitude and energy based ratios, there was no
statistically significant differences between any pair of con-
sidered groups using A2/A1, S2/S1, S5/S1 and A6/A1. Statisti-
cally significant differences (p < 0.05) were found between
CG and POAG for A4/A1, S4/S1, A5/A1 and A6/A1. For the
A3/A1 ratio, significant differences (p < 0.05) were obtained
for CG and GODA and CG and POAG, while for the S3/S1
ratio, significant differences were obtained for CG and
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It was of interest to ascertain whether spectral analysis of
DCT signal could be clinically utilized to evaluate the
shape of the intraocular pulse pressure wave in healthy
eyes, glaucoma suspects (GODA and OHT), and glau-
coma types (POAG and PACG).
Of particular interest was to determine whether differ-
ences in intraocular pressure pulse wave shape between
the groups exist in glaucomatous eyes with sub-normal
levels of IOP.
Evans and colleagues [16] and Božić and colleagues
[17] showed statistically significant differences in the
higher harmonic amplitudes of the IOP pulse wave
spectra between healthy and glaucomatous eyes. Their
subject group size was 10 and 20, respectively. We have
modified their basic signal processing methodologies
and considered amplitude and energy ratios because es-
timating harmonic amplitudes was found not to be ro-
bust when larger groups of subjects were considered.
Note again that spectral analysis of the IOP pulse wave
describes the shape of the signal but not the level of IOP
pressure (in mmHg), which is contained in zero frequency
(constant signal value). This information is not considered
in the spectral analysis because the signals were detrended.
Additionally, the normalization of the higher harmonics to
the first harmonic of the DCT signal makes the analysis re-
sults independent of the OPA value. Such a normalization
is particularly important in studies that involve groups of
subjects with varying IOP and OPA levels, such as consid-
ered by Božić and colleagues [17].
The calculated amplitude and energy ratios showed dis-
tinctive increasing trends with higher harmonics. How-
ever, substantial variability in the higher harmonics was
observed. Of interest could be the results of the third har-
monic ratios (both amplitude and energy). In the study of
Evans and colleagues [16] the third harmonic also led to
the smallest p-value, while Božić and colleagues [17], al-
though considered spectral content up to the fifth har-
monic, showed the results up to the third harmonic.
Worth noting is that spectral analysis of the pulse
pressure signals was the only method among other mea-
sured parameters (GAT IOP, DCT IOP, OPA, HR, and
CCT) that showed significantly different results between
CG and GODA groups. On the other hand, the basic
spectral analysis of Božić and colleagues [17] showed
statistically significant difference between healthy eyes
and those of POAG but not between CG and the normal
tension glaucoma group.
Conclusions
Spectral analysis techniques that take into account the
non-stationary character of the DCT signals and are in-
dependent of IOP and OPA levels could prove to be use-
ful for describing the characteristics of the intraocularpulse pressure wave distinctive to certain types of glau-
comatous eyes or glaucoma suspects. In particular, such
an approach showed the ability to distinguish healthy eyes
from those of suspects with glaucomatous optic disc ap-
pearance. Until now, such discernment could have been
performed examining the optic nerve head and retinal
nerve fiber layer using more expensive devices such as the
OCT, HRT, and scanning laser polarimetry (GDx).
Finally, it is worth noting that the proposed spectral
analysis of intraocular pulse pressure wave has been de-
signed in such a way to phase out any differences in the
levels of IOP and OPA so that all five considered groups
of subjects (two glaucomatous, two suspects, and the
control) could have been compared.
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